Addus HomeCare (ADUS) Scheduled to Post Earnings on Monday

Addus HomeCare (NASDAQ:ADUS) will be announcing its earnings results after the market closes on Monday, May 6th. Analysts expect the company to announce earnings of $0.97 per share for the quarter. Parties interested in participating in the company’s conference call can do so using this link.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings data on Monday, February 26th. The company reported $1.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.04 by $0.17. The business had revenue of $276.35 million during the quarter, compared to analysts’ expectations of $274.02 million. Addus HomeCare had a net margin of 5.91% and a return on equity of 9.70%. On average, analysts expect Addus HomeCare to post $4 EPS for the current fiscal year and $5 EPS for the next fiscal year.

Addus HomeCare Price Performance

Addus HomeCare stock opened at $98.20 on Friday. The stock has a market cap of $1.61 billion, a P/E ratio of 25.25, a price-to-earnings-growth ratio of 1.94 and a beta of 0.96. The company has a fifty day simple moving average of $98.09 and a 200-day simple moving average of $92.08. Addus HomeCare has a 12-month low of $77.30 and a 12-month high of $104.61. The company has a current ratio of 1.38, a quick ratio of 1.38 and a debt-to-equity ratio of 0.18.

Analyst Ratings Changes

A number of research analysts have commented on the stock. William Blair restated an “outperform” rating on shares of Addus HomeCare in a research note on Monday, February 5th. Oppenheimer restated an “outperform” rating and set a $118.00 target price on shares of Addus HomeCare in a research report on Tuesday, March 26th. Barclays downgraded shares of Addus HomeCare from an “equal weight” rating to an “underweight” rating and set a $83.00 price target on the stock. in a report on Tuesday, April 23rd. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and issued a $102.00 price target on shares of Addus HomeCare in a report on Thursday, February 29th. One research analyst has rated the stock with a sell rating and seven have given a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $103.00.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.